Norbergenin prevents LPS-induced inflammatory responses in macrophages through inhibiting NFκB, MAPK and STAT3 activation and blocking metabolic reprogramming

Inflammation is thought to be a key cause of many chronic diseases and cancer. However, current therapeutic agents to control inflammation have limited long-term use potential due to various side-effects. This study aimed to examine the preventive effects of norbergenin, a constituent of traditional...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wan, Cai, Zhengnan, Schindler, Florian, Bahiraii, Sheyda, Brenner, Martin, Heiss, Elke H., Weckwerth, Wolfram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213229/
https://www.ncbi.nlm.nih.gov/pubmed/37251401
http://dx.doi.org/10.3389/fimmu.2023.1117638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213229/
https://www.ncbi.nlm.nih.gov/pubmed/37251401
http://dx.doi.org/10.3389/fimmu.2023.1117638

Ejemplares similares